Significance of Immunotyping by CD8 and PD-L1 Immune Checkpoint Inhibitor in Epithelial Ovarian Carcinoma

被引：0
|
作者：
Srinivasan, Radhika [1 ]
Bansal, Akriti [1 ]
Rohilla, Manish [1 ]
Rai, Bhavana [1 ]
Rajwanshi, Arvind [1 ]
Suri, Vanita [1 ]
Saha, Subhas [2 ]
机构：
[1] Postgrad Inst Med Educ & Res, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Dept Obstet & Gynecol, Chandigarh, India
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1191
引用
收藏
页码：1137 / 1139
页数：3
相关论文
共 50 条
  • [21] PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities
    Peng, Zikun
    Li, Ming
    Li, Huayi
    Gao, Qinglei
    DRUG DISCOVERY TODAY, 2023, 28 (08)
  • [22] Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinoma
    Buderath, Paul
    Mairinger, Fabian
    Mairinger, Elena
    Boehm, Katharina
    Mach, Pawel
    Schmid, Kurt Werner
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    Bankfalvi, Agnes
    Westerwick, Daniela
    Hager, Thomas
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (09) : 1389 - 1395
  • [23] Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
    Chen, Wei-Chung
    Wu, Chun-Chieh
    Chen, Yi-Hsun
    Lee, Jui-Ying
    Wang, Yao-Kuang
    Wu, Nian-Siou
    Wu, Ming-Tsang
    Wu, I-Chen
    BIOMEDICINES, 2022, 10 (08)
  • [24] CD8/PD-L1 immunohistochemical reactivity and gene alterations in cutaneous squamous cell carcinoma
    Nishida, Haruto
    Kondo, Yoshihiko
    Kusaba, Takahiro
    Kawamura, Kazuhiro
    Oyama, Yuzo
    Daa, Tsutomu
    PLOS ONE, 2023, 18 (02):
  • [25] Assessing the Checkpoint Immune System (PD-L1, CD8 and CD163) in HER2-Positive Invasive Breast Carcinoma and Its Association with Clinical and Pathological Features
    Hou, Yanjun
    Nitta, Hiroaki
    Banks, Peter
    Parwani, Anil
    Li, Zaibo
    MODERN PATHOLOGY, 2017, 30 : 47A - 47A
  • [26] Assessing the Checkpoint Immune System (PD-L1, CD8 and CD163) in HER2-Positive Invasive Breast Carcinoma and Its Association with Clinical and Pathological Features
    Hou, Yanjun
    Nitta, Hiroaki
    Banks, Peter
    Parwani, Anil
    Li, Zaibo
    LABORATORY INVESTIGATION, 2017, 97 : 47A - 47A
  • [27] INTRATUMORAL EXPRESSION OF PD-1/PD-L1 IMMUNE CHECKPOINT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Baquerizo, Angeles
    Vavinskaya, Vera
    Rojas, Angela
    Mhoyan, Anna
    Romero-Gomez, Manuel
    Sher, Linda
    Madani, Bahar
    Fisher, Jonathan
    Schaffer, Randolph
    Frenette, Catherine T.
    Marsh, Christopher
    HEPATOLOGY, 2019, 70 : 206A - 206A
  • [28] Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance
    Xin, Haisong
    Zhou, Chaoxi
    Wang, Guanglin
    Liu, Yan
    Zhang, Juan
    Liu, Youqiang
    Li, Baokun
    Zhang, Jianfeng
    Su, Mingming
    Li, Zhihan
    Wang, Guiying
    HELIYON, 2023, 9 (02)
  • [29] The prognostic and predictive roles of a CD8/PD-L1 signature in cancer
    Althammer, Sonja
    Steele, Keith
    Widmaier, Moritz
    Brown, Charles
    Tan, Tze Heng
    Rognoni, Lorenz
    Kaplon, Helene
    Friedrich, David
    Higgs, Brandon W.
    Schmidt, Guenter
    Ranade, Koustubh
    Dieu-Nosjean, Marie-Caroline
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [30] Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
    Ruiting Li
    Xiaojing Zou
    Huaqing Shu
    You Shang
    Intensive Care Research, 2021, 1 (1-2): : 11 - 15
12345